Upper gastrointestinal bleed or perforation still carries a finite risk of death. Differences in study architecture, population characteristics, risk factors, definition of mortality, and reporting of outcomes impose limitations on interpreting effect size. Data published since 1997 suggest that overall mortality in any patient with a bleed or perforation has fallen over time but is still about 1 in 13. Not unexpectedly, mortality is even higher in patients with a bleed or perforation who are exposed to NSAID or aspirin. New knowledge is that in these patients, mortality appears to have increased over time to about 1 in 5 since 1997. Reasons for this increase remain to be elucidated.
Pain Research is supported in part by the Oxford Pain Research Trust, which had no role in design, planning, execution of the study, or in writing the manuscript.Reprint Address
Sebastian Straube, Email: firstname.lastname@example.org
BMC Gastroenterol © 2009 Straube et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this: Mortality With Upper Gastrointestinal Bleeding and Perforation: Effects of Time and NSAID Use - Medscape - Jun 01, 2009.